Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
Abstract Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indica...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.3509 |
id |
doaj-114078d52fed4d0b95de4ae639ca5ab5 |
---|---|
record_format |
Article |
spelling |
doaj-114078d52fed4d0b95de4ae639ca5ab52021-05-21T11:05:45ZengWileyClinical Case Reports2050-09042021-01-019125625910.1002/ccr3.3509Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndromeTamer Mohamed Zaalouk0Zouheir Ibrahim Bitar1Ossama Sajeh Maadarani2Mohamed Elsayed Elhabibi3Critical Care Unit Ahmadi Hospital Kuwait Oil Company Ahmadi KuwaitCritical Care Unit Ahmadi Hospital Kuwait Oil Company Ahmadi KuwaitCritical Care Unit Ahmadi Hospital Kuwait Oil Company Ahmadi KuwaitCritical Care Unit Ahmadi Hospital Kuwait Oil Company Ahmadi KuwaitAbstract Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indicated. We would like to alert all physicians that carbamazepine should be avoided in any patient with a previous history of drug reaction such as mast cell activation syndrome.https://doi.org/10.1002/ccr3.3509carbamazepinemast cell activation syndromemethotrexateStevens‐Johnson syndrome |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tamer Mohamed Zaalouk Zouheir Ibrahim Bitar Ossama Sajeh Maadarani Mohamed Elsayed Elhabibi |
spellingShingle |
Tamer Mohamed Zaalouk Zouheir Ibrahim Bitar Ossama Sajeh Maadarani Mohamed Elsayed Elhabibi Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome Clinical Case Reports carbamazepine mast cell activation syndrome methotrexate Stevens‐Johnson syndrome |
author_facet |
Tamer Mohamed Zaalouk Zouheir Ibrahim Bitar Ossama Sajeh Maadarani Mohamed Elsayed Elhabibi |
author_sort |
Tamer Mohamed Zaalouk |
title |
Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
title_short |
Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
title_full |
Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
title_fullStr |
Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
title_full_unstemmed |
Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
title_sort |
carbamazepine‐induced stevens‐johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
publisher |
Wiley |
series |
Clinical Case Reports |
issn |
2050-0904 |
publishDate |
2021-01-01 |
description |
Abstract Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indicated. We would like to alert all physicians that carbamazepine should be avoided in any patient with a previous history of drug reaction such as mast cell activation syndrome. |
topic |
carbamazepine mast cell activation syndrome methotrexate Stevens‐Johnson syndrome |
url |
https://doi.org/10.1002/ccr3.3509 |
work_keys_str_mv |
AT tamermohamedzaalouk carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome AT zouheiribrahimbitar carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome AT ossamasajehmaadarani carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome AT mohamedelsayedelhabibi carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome |
_version_ |
1721432163653517312 |